CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 10 enrolled
Drug / intervention
CONTINUUM™device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01083199
NCT01083199Phase 4Completed
CompareCT.gov

Global Performance Evaluation of the AMS CONTINUUM™ Device in Facilitating Vesico-Urethral Anastomosis Following a Radical Prostatectomy

American Medical Systems·interventional·Posted Mar 9, 2010·Updated Apr 12, 2016

In Brief

A Phase 4 clinical trial evaluating CONTINUUM™ for Prostate Cancer. Completed, enrolled 10 participants across 2 sites in 2 countries.

Detailed Summary

1. To evaluate Device performance in providing mucosa to mucosa apposition to facilitate sustainable vesico-urethral anastomosis during a radical prostatectomy procedure. 2. To assess clinical outcomes of the Device in facilitating the vesico-urethral anastomosis following a radical prostatectomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesGreece, Spain
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 9, 2010
Enrollment StartOct 1, 2007
Primary CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 16.3 years ago

Interventions

CONTINUUM™device

Performance of CONTINUUM™ in facilitating the vesico-urethral anastomosis following radical prostatectomy.